Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02913261
Brief Title: Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation (REACH2)

First Submitted : September 18, 2016
First Submitted that Met QC Criteria : September 21, 2016
First Posted : September 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 1, 2021
Last Update Posted : September 2, 2021